2017 Fiscal Year Final Research Report
Analysis of quasispecies of HBV / HCV genes in a single individual by a new sequencing technique
Project/Area Number |
15K08995
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Gastroenterology
|
Research Institution | University of Yamanashi |
Principal Investigator |
SAKAMOTO Minoru 山梨大学, 大学院総合研究部, 准教授 (60324191)
|
Co-Investigator(Kenkyū-buntansha) |
榎本 信幸 山梨大学, 大学院総合研究部, 教授 (20251530)
|
Project Period (FY) |
2015-04-01 – 2018-03-31
|
Keywords | HBV / HCV / quasispecies |
Outline of Final Research Achievements |
The quasispecies state of HBV, HCV genome was analyzed by new sequencing technology. In HCV, the drug resistance mutation against DAA is minor clone so called drug resistant associated variants: RAV becomes dominant after treatment. In HBV, quasispecies state in which deletion mutant of HBV-PreS2 region and Pre S1 / S2 initiation codon mutation are existed. It is formed by persistent infection with or without antiviral treatment and existent ratio 1% or more is associated with the disease state. Further In HCC cases, an increase in the existent ratio of mutated clone in PreS2 region is closely related to liver carcinogenesis.
|
Free Research Field |
消化器内科学
|